advertisement
Yamamoto T 24
Showing records 1 to 24 | Display all abstracts from Yamamoto T61441 Additive Intraocular Pressure-Lowering Effects of the Rho Kinase Inhibitor Ripasudil (K-115) Combined With Timolol or Latanoprost: A Report of 2 Randomized Clinical Trials
Tanihara H
JAMA ophthalmology 2015; 133: 755-761
61017 Progression to Legal Blindness in Patients With Normal Tension Glaucoma: Hospital-Based Study
Sawada A
Investigative Ophthalmology and Visual Science 2015; 56: 3635-3641
61521 Changes in filtering bleb morphology after bleb-related infection
Sawada A
Japanese Journal of Ophthalmology 2015; 59: 312-317
61362 Fluctuation of Bacteria on Bleb Surface After Trabeculectomy With Adjunctive Mitomycin C
Takahashi N
Journal of Glaucoma 2016; 25: 433-439
61705 Development of Glaucomatous Visual Field Defects in Preperimetric Glaucoma Patients Within 3 Years of Diagnosis
Inuzuka H
Journal of Glaucoma 2016; 25: e591-e595
61521 Changes in filtering bleb morphology after bleb-related infection
Kuwayama Y
Japanese Journal of Ophthalmology 2015; 59: 312-317
61017 Progression to Legal Blindness in Patients With Normal Tension Glaucoma: Hospital-Based Study
Rivera JA
Investigative Ophthalmology and Visual Science 2015; 56: 3635-3641
61705 Development of Glaucomatous Visual Field Defects in Preperimetric Glaucoma Patients Within 3 Years of Diagnosis
Kawase K
Journal of Glaucoma 2016; 25: e591-e595
61441 Additive Intraocular Pressure-Lowering Effects of the Rho Kinase Inhibitor Ripasudil (K-115) Combined With Timolol or Latanoprost: A Report of 2 Randomized Clinical Trials
Inoue T
JAMA ophthalmology 2015; 133: 755-761
61362 Fluctuation of Bacteria on Bleb Surface After Trabeculectomy With Adjunctive Mitomycin C
Sawada A
Journal of Glaucoma 2016; 25: 433-439
61017 Progression to Legal Blindness in Patients With Normal Tension Glaucoma: Hospital-Based Study
Takagi D
Investigative Ophthalmology and Visual Science 2015; 56: 3635-3641
61441 Additive Intraocular Pressure-Lowering Effects of the Rho Kinase Inhibitor Ripasudil (K-115) Combined With Timolol or Latanoprost: A Report of 2 Randomized Clinical Trials
Yamamoto T
JAMA ophthalmology 2015; 133: 755-761
61362 Fluctuation of Bacteria on Bleb Surface After Trabeculectomy With Adjunctive Mitomycin C
Mochizuki K
Journal of Glaucoma 2016; 25: 433-439
61521 Changes in filtering bleb morphology after bleb-related infection
Yamamoto T
Japanese Journal of Ophthalmology 2015; 59: 312-317
61705 Development of Glaucomatous Visual Field Defects in Preperimetric Glaucoma Patients Within 3 Years of Diagnosis
Sawada A; Kokuzawa S
Journal of Glaucoma 2016; 25: e591-e595
61362 Fluctuation of Bacteria on Bleb Surface After Trabeculectomy With Adjunctive Mitomycin C
Katada T
Journal of Glaucoma 2016; 25: 433-439
61017 Progression to Legal Blindness in Patients With Normal Tension Glaucoma: Hospital-Based Study
Nishida T
Investigative Ophthalmology and Visual Science 2015; 56: 3635-3641
61441 Additive Intraocular Pressure-Lowering Effects of the Rho Kinase Inhibitor Ripasudil (K-115) Combined With Timolol or Latanoprost: A Report of 2 Randomized Clinical Trials
Kuwayama Y; Abe H
JAMA ophthalmology 2015; 133: 755-761
61017 Progression to Legal Blindness in Patients With Normal Tension Glaucoma: Hospital-Based Study
Yamamoto T
Investigative Ophthalmology and Visual Science 2015; 56: 3635-3641
61705 Development of Glaucomatous Visual Field Defects in Preperimetric Glaucoma Patients Within 3 Years of Diagnosis
Ishida K
Journal of Glaucoma 2016; 25: e591-e595
61362 Fluctuation of Bacteria on Bleb Surface After Trabeculectomy With Adjunctive Mitomycin C
Yamamoto T
Journal of Glaucoma 2016; 25: 433-439
61441 Additive Intraocular Pressure-Lowering Effects of the Rho Kinase Inhibitor Ripasudil (K-115) Combined With Timolol or Latanoprost: A Report of 2 Randomized Clinical Trials
Suganami H
JAMA ophthalmology 2015; 133: 755-761
61705 Development of Glaucomatous Visual Field Defects in Preperimetric Glaucoma Patients Within 3 Years of Diagnosis
Yamamoto T
Journal of Glaucoma 2016; 25: e591-e595
61441 Additive Intraocular Pressure-Lowering Effects of the Rho Kinase Inhibitor Ripasudil (K-115) Combined With Timolol or Latanoprost: A Report of 2 Randomized Clinical Trials
Araie M;
JAMA ophthalmology 2015; 133: 755-761
